文献

J-GLOBAL ID：201802238724791181   整理番号：18A0625427

ヘモグロビンA1c基準に従って新たに診断された糖尿病を合併した脳内出血の予後

Prognosis of Intracerebral Hemorrhage with Newly Diagnosed Diabetes Mellitus According to Hemoglobin A1c Criteria

著者 (43件)： Zhang Xinmiao (Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China) ,  Zhang Xinmiao (China National Clinical Research Center for Neurological Diseases, Beijing, China) ,  Zhang Xinmiao (Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China) ,  Zhang Xinmiao (Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China) ,  Jing Jing (Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China) ,  Jing Jing (China National Clinical Research Center for Neurological Diseases, Beijing, China) ,  Jing Jing (Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China) ,  Jing Jing (Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China) ,  Zheng Huaguang (Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China) ,  Zheng Huaguang (China National Clinical Research Center for Neurological Diseases, Beijing, China) ,  Zheng Huaguang (Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China) ,  Zheng Huaguang (Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China) ,  Jia Qian (Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China) ,  Jia Qian (China National Clinical Research Center for Neurological Diseases, Beijing, China) ,  Jia Qian (Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China) ,  Jia Qian (Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China) ,  Zhao Xingquan (Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China) ,  Zhao Xingquan (China National Clinical Research Center for Neurological Diseases, Beijing, China) ,  Zhao Xingquan (Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China) ,  Zhao Xingquan (Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China) ,  Liu Liping (Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China) ,  Liu Liping (China National Clinical Research Center for Neurological Diseases, Beijing, China) ,  Liu Liping (Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China) ,  Liu Liping (Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China) ,  Wang Chunxue (Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China) ,  Wang Chunxue (China National Clinical Research Center for Neurological Diseases, Beijing, China) ,  Wang Chunxue (Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China) ,  Wang Chunxue (Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China) ,  Meng Xia (Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China) ,  Meng Xia (China National Clinical Research Center for Neurological Diseases, Beijing, China) ,  Meng Xia (Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China) ,  Meng Xia (Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China) ,  Pan Yuesong (Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China) ,  Pan Yuesong (Department of Epidemiology and Health Statistics, School of Public Health, Capital Medical University, Beijing, China) ,  Pan Yuesong (Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China) ,  Wang Yilong (Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China) ,  Wang Yilong (China National Clinical Research Center for Neurological Diseases, Beijing, China) ,  Wang Yilong (Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China) ,  Wang Yilong (Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China) ,  Wang Yongjun (Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China) ,  Wang Yongjun (China National Clinical Research Center for Neurological Diseases, Beijing, China) ,  Wang Yongjun (Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China) ,  Wang Yongjun (Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China)
資料名： Journal of Stroke & Cerebrovascular Diseases  (Journal of Stroke & Cerebrovascular Diseases)
巻： 27  号： 5  ページ： 1127-1133  発行年： 2018年05月 
JST資料番号： W1420A  ISSN： 1052-3057  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： ヘモグロビンA1c(HbA1c)は糖尿病(DM)診断に推奨さ...

シソーラス用語： 前向きコホート研究 ,...
準シソーラス用語： 診断基準

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0625427&from=J-GLOBAL&jstjournalNo=W1420A") }}

著者キーワード (4件)： 脳内出血 ,  糖尿病 ,  予後 ,  危険因子

分類 (2件)： 神経系の診断  (GN02000H) ,  代謝異常・栄養性疾患の診断  (GD05020U)

タイトルに関連する用語 (6件)： ヘモグロビンA1C ,  診断 ,  糖尿病 ,  合併 ,  脳内出血 ,  予後